Investor presentation
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your FAB notes
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that it will host an online live presentation on Thursday, 22 May at 11.30am, delivered by Dr Adrian Kinkaid, CEO and Stephen Smyth, interim CFO to accompany the recent trading update. The Company is committed to providing an opportunity for all existing and potential investors to hear directly from management, who will discuss the recent trading update for FY 2025.
The presentation will be hosted through the digital platform Investor Meet Company ("IMC").
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.